NUMB and breast cancer: To determine whether loss of Numb expression is critical for the maintenance of the CSC pool, we selected four Numb− human BCs (T1–T4) displaying the typical clinical–pathological parameters that characterize this type of aggressive BC (Pece et al, 2004) (Fig 1A).